srch

Jan 04, 2022 · FOSTER CITY, Calif., January 04, 2022--Mirum Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022

Mirum Pharmaceuticals is a biotech company launched in San Francisco with its European headquarters located in Basel. Mirum's pipeline consists of two ...

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases.

View Mirum Pharmaceuticals (mirumpharma.com) location in California, United States , revenue, industry and description. Find related and similar companies ...

16.12.2021 · Mirum Pharmaceuticals, Inc. ( MIRM) is a Foster City, California-based biopharmaceutical concern focused on the development of treatments for rare liver diseases. In September 2021, the company...

Pharmaceuticals Company size 51-200 employees Headquarters Foster City, CA Type Public Company Founded 2018 Locations Primary 950 Tower Lane …

13.01.2022 · Mirum Pharmaceuticals, Inc. (MIRM) Company Description Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Jan 11, 2022 · Mirum Pharmaceuticals Provides Business Update and Highlights Key 2022 Corporate Milestones - Unaudited estimated total LIVMARLI net product revenue of $3.0 million for fourth quarter 2021 ...

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

13.01.2022 · Mirum Pharmaceuticals, Inc is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat.

Mirum is creating transformative medicine for children with rare cholestatic liver disease. https://mirumpharma.com/. (650) 667-4085. Pharmaceutical Company.

Home - Mirum Pharma Developing medicines with the potential to change lives Where others see unmet need solely as a treatment gap, we envision a unique opportunity to revitalize a community like never before.

Mirum Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company develops therapies for the treating of cholestatic liver diseases.

Compliance | Mirum Pharma Compliance oversight Mirum has designated a chief compliance officer (CCO) responsible for developing, overseeing, and monitoring the operation of our Compliance Program. Our CCO reports to the chief executive officer.

Mirum Pharmaceuticals (NASDAQ: MIRM) is dedicated to creating life-changing therapies for patients with liver diseases. We are advancing our lead product candidate for Alagille syndrome (ALGS) and ...

Jan 11, 2022 · Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI™ (maralixibat) oral solution which ...

16.12.2021 · Mirum Pharmaceuticals, Inc is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat.

In Latin, “mirum” means remarkable. In science, we develop remarkable therapies for a deserving community. When we discovered that there was an unmet need ...

Mirum Pharmaceuticals Provides Business Update and Highlights Key 2022 Corporate Milestones Mirum Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022 Mirum Pharmaceuticals Added to NASDAQ Biotechnology Index

05.01.2022 · Mirum Pharmaceuticals, Inc is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat.

Jan 05, 2022 · Mirum Pharmaceuticals, Inc is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat.

Mirum Pharmaceuticals | 10567 followers on LinkedIn. Creating transformative medicine for children with rare cholestatic liver disease.

15.12.2021 · Investor Relations | Mirum Pharmaceuticals, Inc. Investor Relations Company Overview In Latin, “mirum” means remarkable. In science, we develop remarkable therapies for a deserving community. When we discovered that there was an unmet need for people living with rare liver disease, we got to work.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a late-stage ...

Dec 16, 2021 · Mirum Pharmaceuticals, Inc. ( MIRM) is a Foster City, California-based biopharmaceutical concern focused on the development of treatments for rare liver diseases. In September 2021, the company ...

In Latin, “mirum” means remarkable. In science, we develop remarkable therapies for a deserving community. When we discovered that there was an unmet need for ...